文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

标题:甲酯 4-(7-羟基-4,4,8-三甲基-3-氧杂二环[3.3.1]壬烷-2-基)苯甲酸酯的合成与评价及其与米替福新的协同抗利什曼原虫作用

Synthesis and Evaluation of Methyl 4-(7-Hydroxy-4,4,8-Trimethyl-3-Oxabicyclo[3.3.1]Nonan-2-yl)Benzoate as an Antileishmanial Agent and Its Synergistic Effect with Miltefosine.

机构信息

Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam, India.

Department of Chemistry, Indian Institute of Technology Guwahati, Assam, India.

出版信息

Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01810-17. Print 2018 Feb.


DOI:10.1128/AAC.01810-17
PMID:29133553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5786811/
Abstract

In our interest in oxabicyclic compounds as potent antileishmanial agents, the present work deals with the chemical synthesis of a new oxabicyclic derivative, methyl 4-(7-hydroxy-4,4,8-trimethyl-3-oxabicyclo[3.3.1]nonan-2-yl)benzoate (PS-207). This oxabicyclic derivative showed a good antileishmanial effect on the parasite, on both the promastigote and the amastigote. The mode of parasitic death from PS-207 seemed to be apoptosis-like. Interestingly, the combination of PS-207 with a low dose of miltefosine showed a synergistic effect against the parasite.

摘要

在我们对作为强效抗利什曼原虫药物的氧杂双环化合物的研究兴趣中,本工作涉及一种新的氧杂双环衍生物——甲酯 4-(7-羟基-4,4,8-三甲基-3-氧杂双环[3.3.1]壬烷-2-基)苯甲酸酯(PS-207)的化学合成。该氧杂双环衍生物对寄生虫表现出良好的抗利什曼原虫作用,无论是对前鞭毛体还是无鞭毛体。PS-207 引起寄生虫死亡的方式似乎类似于细胞凋亡。有趣的是,PS-207 与低剂量米替福新联合使用对寄生虫表现出协同作用。

相似文献

[1]
Synthesis and Evaluation of Methyl 4-(7-Hydroxy-4,4,8-Trimethyl-3-Oxabicyclo[3.3.1]Nonan-2-yl)Benzoate as an Antileishmanial Agent and Its Synergistic Effect with Miltefosine.

Antimicrob Agents Chemother. 2018-1-25

[2]
Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

Antimicrob Agents Chemother. 2015-12

[3]
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.

Int J Antimicrob Agents. 2007-9

[4]
In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.

Exp Parasitol. 2018-1

[5]
Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.

Antimicrob Agents Chemother. 2018-11-26

[6]
CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.

J Antimicrob Chemother. 2010-5-22

[7]
15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.

J Mol Med (Berl). 2016-6

[8]
Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.

Antimicrob Agents Chemother. 2017-2-23

[9]
Possible mechanism of miltefosine-mediated death of Leishmania donovani.

Antimicrob Agents Chemother. 2004-8

[10]
Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.

ChemMedChem. 2015-3

本文引用的文献

[1]
Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani.

Sci Rep. 2017-3-7

[2]
Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

Antimicrob Agents Chemother. 2015-12

[3]
Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania.

Acta Trop. 2015-5

[4]
Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen.

Eur J Pharm Biopharm. 2013-11

[5]
In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.

J Antimicrob Chemother. 2013-8-22

[6]
Leishmaniasis worldwide and global estimates of its incidence.

PLoS One. 2012-5-31

[7]
Leishmaniasis: current status of available drugs and new potential drug targets.

Asian Pac J Trop Med. 2012-6

[8]
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use.

Clin Infect Dis. 2012-5-9

[9]
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.

PLoS Negl Trop Dis. 2010-9-7

[10]
Flow cytometric screening for anti-leishmanials in a human macrophage cell line.

Exp Parasitol. 2010-6-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索